← FDA Warning Letters

Central Coast Multispecialty Medical Group, Inc.

FDA Warning Letter · 2026-02-10 · Center for Biologics Evaluation and Research (CBER)

Letter

Company
Central Coast Multispecialty Medical Group, Inc.
Posted Date
2026-02-10
Letter Issue Date
2026-01-29
Issuing Office
Center for Biologics Evaluation and Research (CBER)

Subject

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown